Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

Vascular Solutions announces re-launch of Venture catheter

Vascular Solutions, Inc. (Nasdaq:VASC) today announced that it has re-launched the Venture catheter, a deflectable-tip catheter used to provide guidewire directional control in challenging coronary and peripheral interventional procedures. The device is available immediately in the United States and expected to become available in select international markets over the next few months.

Gibson describes Boston cases as battlefield injuries

NPR’s “All Things Considered” interviewed C. Michael Gibson, MD, about his experiences treating victims of the explosions at the Boston Marathon. Gibson, a cardiologist at Beth Israel Deaconess Medical Center in Boston, credited the medical teams in the field and the proximity of the emergency tent for stabilizing the wounded. “[They] may have saved innumerable lives,” he said.

Data published in JACC: Cardiovascular Interventions show that OrbusNeich’s COMBO Dual Therapy Stent reaches primary study endpoint and is effective in controlling neointimal proliferation

OrbusNeich today announced that data from the REMEDEE (Randomized Evaluation of an abluMinal sirolimus coatED bio-Engineered stEnt) study published online in JACC: Cardiovascular Interventions demonstrated that the COMBO Dual Therapy Stent met the study’s primary endpoint and was found to be effective in controlling neointimal proliferation.

Talk about distribution channels: SCAI on CNN

A Q&A posted on CNN’s website featured John P. Reilly, MD, editor-in-chief of the Society of Cardiovascular Angiography and Interventions’ secondscount.org and a vice chairman and cardiology fellowship program director at Ochsner Medical Center in New Orleans.

Terumo Cardiovascular Systems announces U.S. distribution agreement with Nonin Medical for Nonin's EQUANOX™ 7600 Regional Oximetry System

Terumo Cardiovascular Systems today announced that it has entered into a multi-year distribution agreement with Nonin Medical, Inc., a leader in noninvasive medical monitoring. Beginning May 1, 2013, Terumo CVS will distribute Nonin's EQUANOX™ Model 7600 Regional Oximetry System to adult and pediatric cardiovascular hospitals in the United States.

Thoracic Surgery: New Alliance Under ICD-10

Thoracic surgeons may find that accurate coding and billing under ICD-10 may require a higher level of specificity than before. 

Thumbnail

Optimizing PCI Outcomes: The Right Tools for the Best Results

St. Jude Medical

To optimize outcomes for PCI procedures, new technologies have emerged to assist interventionalists with patient selection, clinical decision making and post-stent assessment.

EuroPCR: Resolute trends positively vs. Xience in all-comers trial

Medtronics Resolute zotarolimus-eluting stent was found to be as safe and effective as Abbott Vasculars Xience V everolimus-eluting stent in a predominantly off-label population, based on the results of the RESOLUTE all-comers trial, presented Tuesday by Patrick W. Serruys MD, PhD, at EuroPCR in Paris. Slides

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Trimed Popup
Trimed Popup